Unknown

Dataset Information

Clinical and microarray analysis of breast cancers of all subtypes from two prospective preoperative chemotherapy studies.


ABSTRACT:

Background

We aimed to analyse clinical and gene expression profiles to predict pathologic complete response and disease-free survival using two consecutive, prospective, preoperative chemotherapy trial cohorts.

Methods

Clinicopathological and gene expression data were evaluated in a cohort from two consecutive phase II preoperative studies that included patients with stage IIA-IIIC breast cancer of all subtypes. Analysed specimens were obtained before preoperative chemotherapy, and cDNA microarray analyses were performed using the Affymetrix Gene Chip U133 plus 2.0.

Results

Between December 2005 and December 2010, 122 patients were analysed. The pathologic complete response rate was significantly higher in HER2+ and HR-/HER2- cancers. Age, pathologic complete respons

SUBMITTER: Okuma HS 

PROVIDER: S-EPMC4985347 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature